Axsome Therapeutics, Inc. LOGO

Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. (NASDAQ:AXSM), is a clinical stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”AXSM” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://axsome.com
Disease Focus
Development Stage
STOCK CODENASDAQ: AXSM
Address
25 Broadway, 9th Floor, NY 10004
New York
United States
Email
Contact Number
+1 212-332-3241

Axsome Therapeutics, Inc. (NASDAQ:AXSM), is a clinical stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders.

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/axsome-therapeutics-inc-” connections=”true” suffix=””]

As per discloser, Axsome Therapeutics, was having $48.0 million of cash as of December 31, 2015 to fund the clinical development of its two major programs.